Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass.
Angelini
G D
GD
Cooper
G J
GJ
Lamarra
M
M
Bryan
A J
AJ
D000208:Acute Disease; D000328:Adult; D007611:Aprotinin / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D004341:Drug Evaluation; D005260:Female; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D007611:Aprotinin